Reuters logo
BRIEF-Shanghai Fosun Pharma's unit gets licensing from Palatin to sell products in greater China
September 6, 2017 / 9:49 AM / 19 days ago

BRIEF-Shanghai Fosun Pharma's unit gets licensing from Palatin to sell products in greater China

Sept 6 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says unit gets licensing from U.S. Palatin Technologies to manufacture and sell bremelanotide medicines in greater China

Source text in Chinese: bit.ly/2wEJUmT

Further company coverage: (Reporting by Hong Kong newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below